Ranniery Acuña-Cordero

TL;DR: This study aimed to evaluate the cost‐utility of MS in asthma exacerbations and found that intravenous magnesium sulfate should be considered a second‐line drug for managing pediatric asthma exacerbation.

TL;DR: It is shown that respiratory viruses are significant causes of ALRI in infants and young children in Colombia, a typical tropical LMIC, especially during the rainy season, and that clinical variables such as a history of pulmonary hypertension and ahistory of recurrent wheezing are more relevant for predicting ALRI severity than the infecting respiratory viruses.

TL;DR: In this paper, the authors performed a systematic and exhaustive search of CPGs on bronchiolitis published from 2000 to 2014, and three independent appraisers assessed the quality of the CPG using the Appraisal of Guidelines Research and Evaluation (AGREE) II instrument.

TL;DR: In this article, the authors concluded that older infants with rhinovirus (RV) bronchiolitis, especially those with a nasopharyngeal microbiome dominated by Haemophilus influenzae, those affected during nonpeak months or during non-respiratory syncytial virus (RSV) predominant months, those with wheezing at presentation, and those with clinical characteristics such as atopic dermatitis or a family history of asthma in a first-degree relative, have the greatest likelihood of benefiting from albuterol.

TL;DR: Duration of mechanical ventilation, duration of subsequent ambulatory oxygen therapy, and breastfeeding in females were independently associated with the number of hospitalizations for ALRIs in a population of infants with a history of BPD.